Onyvax Limited

USPTO Granted Patents = 7

% Expired Patents = 42.9

EPO Patents = 1

Forward Citations = 21

Loading Chart...

5 inventors (with patents filed for the assignee):

Angus Dalgleish (6 out of 18 patents)

Anthony Ian Walker (6 out of 7 patents)

Andrew Derek Sutton (4 out of 4 patents)

4. Peter Michael Smith (3 out of 3 patents)

5. Peter Thraves (1 out of 1 patent)

6. Peter Onyvax Limited Thraves (0 patent)

7. Andrew Onyvax Limited Sutton (0 patent)

7 patents: Sort by Forward Citations

1. 8545835 - Human prostate cell lines in cancer treatment (2013-10-01),

2. 8097244 - Human prostate cell lines in cancer treatment (2012-01-17),

3. 8034360 - Use of human prostate cell lines in cancer treatment (2011-10-11),

4. 7438922 - Human prostate cell lines in cancer treatment (2008-10-21),

5. 7303911 - Prostate cell lines (2007-12-04),

6. 6972128 - Use of human prostrate cell lines in prostate cancer treatment (2005-12-06),

7. 6699483 - Cancer treatments (2004-03-02),

Company Overview

Onyvax Limited is a biotechnology company specializing in the development of cancer vaccines. The company's innovative approach focuses on creating personalized immunotherapies to target a wide array of cancer types. Onyvax's cutting-edge research and development efforts aim to revolutionize cancer treatment and improve patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

7 Patents

#169 in

#2,340 in United Kingdom

GB

Onyvax Limited

Forward Citations = 21

5 inventors:

Angus Dalgleish (6 out of 18 patents)

Anthony Ian Walker (6 out of 7 patents)

Andrew Derek Sutton (4 out of 4 patents)

4. Peter Michael Smith (3 out of 3 patents)

5. Peter Thraves (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Onyvax Limited. Retrieved from https://idiyas.com/company/onyvax

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]